167 related articles for article (PubMed ID: 8547539)
1. Exogenous hormone use and the risk of postmenopausal breast cancer: results from The Netherlands Cohort Study.
Schuurman AG; van den Brandt PA; Goldbohm RA
Cancer Causes Control; 1995 Sep; 6(5):416-24. PubMed ID: 8547539
[TBL] [Abstract][Full Text] [Related]
2. Combined effect of oral contraceptive use and hormone replacement therapy on breast cancer risk in postmenopausal women.
Norman SA; Berlin JA; Weber AL; Strom BL; Daling JR; Weiss LK; Marchbanks PA; Bernstein L; Voigt LF; McDonald JA; Ursin G; Liff JM; Burkman RT; Malone KE; Simon MS; Folger SG; Deapen D; Wingo PA; Spirtas R
Cancer Causes Control; 2003 Dec; 14(10):933-43. PubMed ID: 14750532
[TBL] [Abstract][Full Text] [Related]
3. Hormone replacement therapy and breast cancer in former users of oral contraceptives--The Norwegian Women and Cancer study.
Lund E; Bakken K; Dumeaux V; Andersen V; Kumle M
Int J Cancer; 2007 Aug; 121(3):645-8. PubMed ID: 17372914
[TBL] [Abstract][Full Text] [Related]
4. Hormone replacement therapy and risk of breast cancer with a favorable histology: results of the Iowa Women's Health Study.
Gapstur SM; Morrow M; Sellers TA
JAMA; 1999 Jun; 281(22):2091-7. PubMed ID: 10367819
[TBL] [Abstract][Full Text] [Related]
5. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
Tworoger SS; Missmer SA; Barbieri RL; Willett WC; Colditz GA; Hankinson SE
J Natl Cancer Inst; 2005 Apr; 97(8):595-602. PubMed ID: 15840882
[TBL] [Abstract][Full Text] [Related]
6. Sex steroid hormones and breast cancer: is there a link with oral contraceptives and hormone replacement therapy?
Khoo SK; Chick P
Med J Aust; 1992 Jan; 156(2):124-32. PubMed ID: 1736053
[TBL] [Abstract][Full Text] [Related]
7. Sex hormones and cardiovascular risk.
La Vecchia C
Hum Reprod; 1992 Feb; 7(2):162-7. PubMed ID: 1577926
[TBL] [Abstract][Full Text] [Related]
8. Female hormone utilisation and risk of hepatocellular carcinoma.
Tavani A; Negri E; Parazzini F; Franceschi S; La Vecchia C
Br J Cancer; 1993 Mar; 67(3):635-7. PubMed ID: 8382515
[TBL] [Abstract][Full Text] [Related]
9. Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer.
Grabrick DM; Hartmann LC; Cerhan JR; Vierkant RA; Therneau TM; Vachon CM; Olson JE; Couch FJ; Anderson KE; Pankratz VS; Sellers TA
JAMA; 2000 Oct; 284(14):1791-8. PubMed ID: 11025831
[TBL] [Abstract][Full Text] [Related]
10. Oral contraceptives, hormone replacement therapy and breast cancer risk: a cohort study of 16 928 women 48 years and older.
Thorbjarnardottir T; Olafsdottir EJ; Valdimarsdottir UA; Olafsson O; Tryggvadottir L
Acta Oncol; 2014 Jun; 53(6):752-8. PubMed ID: 24460068
[TBL] [Abstract][Full Text] [Related]
11. Oral contraceptives and breast cancer: a cooperative Italian study.
La Vecchia C; Negri E; Franceschi S; Talamini R; Amadori D; Filiberti R; Conti E; Montella M; Veronesi A; Parazzini F
Int J Cancer; 1995 Jan; 60(2):163-7. PubMed ID: 7829209
[TBL] [Abstract][Full Text] [Related]
12. Oral contraceptives and risk of breast cancer in women aged 20-54 years. Netherlands Oral Contraceptives and Breast Cancer Study Group.
Rookus MA; van Leeuwen FE
Lancet; 1994 Sep; 344(8926):844-51. PubMed ID: 7916400
[TBL] [Abstract][Full Text] [Related]
13. Type of postmenopausal hormone use and risk of breast cancer: 12-year follow-up from the Nurses' Health Study.
Colditz GA; Stampfer MJ; Willett WC; Hunter DJ; Manson JE; Hennekens CH; Rosner BA; Speizer FE
Cancer Causes Control; 1992 Sep; 3(5):433-9. PubMed ID: 1525324
[TBL] [Abstract][Full Text] [Related]
14. Oral contraceptives and breast cancer risk in Taiwan, a country of low incidence of breast cancer and low use of oral contraceptives.
Chie WC; Li CY; Huang CS; Chang KJ; Yen ML; Lin RS
Int J Cancer; 1998 Jul; 77(2):219-23. PubMed ID: 9650556
[TBL] [Abstract][Full Text] [Related]
15. Prospective study of exogenous hormones and risk of pulmonary embolism in women.
Grodstein F; Stampfer MJ; Goldhaber SZ; Manson JE; Colditz GA; Speizer FE; Willett WC; Hennekens CH
Lancet; 1996 Oct; 348(9033):983-7. PubMed ID: 8855854
[TBL] [Abstract][Full Text] [Related]
16. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
Colditz GA; Hankinson SE; Hunter DJ; Willett WC; Manson JE; Stampfer MJ; Hennekens C; Rosner B; Speizer FE
N Engl J Med; 1995 Jun; 332(24):1589-93. PubMed ID: 7753136
[TBL] [Abstract][Full Text] [Related]
17. Use of oral contraceptives and breast cancer risk: The Norwegian-Swedish Women's Lifestyle and Health Cohort Study.
Kumle M; Weiderpass E; Braaten T; Persson I; Adami HO; Lund E
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1375-81. PubMed ID: 12433714
[TBL] [Abstract][Full Text] [Related]
18. Previous oral contraceptive use and breast cancer risk according to hormone replacement therapy use among postmenopausal women.
Dumeaux V; Fournier A; Lund E; Clavel-Chapelon F
Cancer Causes Control; 2005 Jun; 16(5):537-44. PubMed ID: 15986108
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer among young U.S. women in relation to oral contraceptive use.
White E; Malone KE; Weiss NS; Daling JR
J Natl Cancer Inst; 1994 Apr; 86(7):505-14. PubMed ID: 8133534
[TBL] [Abstract][Full Text] [Related]
20. Oral contraceptives and breast cancer. A prospective cohort study.
Lipnick RJ; Buring JE; Hennekens CH; Rosner B; Willett W; Bain C; Stampfer MJ; Colditz GA; Peto R; Speizer FE
JAMA; 1986 Jan; 255(1):58-61. PubMed ID: 3940306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
